Equities

Mercator Medical SA

Mercator Medical SA

Actions
  • Price (EUR)11.76
  • Today's Change-0.32 / -2.65%
  • Shares traded0.00
  • 1 Year change+31.40%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of PLN
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments217223340
Total Receivables, Net10571126
Total Inventory148201230
Prepaid expenses5.344.0123
Other current assets, total110198196
Total current assets585698914
Property, plant & equipment, net255285336
Goodwill, net------
Intangibles, net33259.65
Long term investments6846--
Note receivable - long term00.060.10
Other long term assets------
Total assets9651,0831,289
LIABILITIES
Accounts payable533657
Accrued expenses141344
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.000.931.31
Other current liabilities, total101031
Total current liabilities7860133
Total long term debt4.412.463.52
Total debt5.413.394.83
Deferred income tax218.544.35
Minority interest(2.38)0.491.36
Other liabilities, total1.762.892.39
Total liabilities10374145
SHAREHOLDERS EQUITY
Common stock111111
Additional paid-in capital315858
Retained earnings (accumulated deficit)8558881,079
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(34)52(3.42)
Total equity8621,0091,144
Total liabilities & shareholders' equity9651,0831,289
Total common shares outstanding9.779.779.77
Treasury shares - common primary issue0.880.880.88
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.